Search

Your search keyword '"Atkin S"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Atkin S" Remove constraint Author: "Atkin S" Topic diabetes mellitus, type 2 Remove constraint Topic: diabetes mellitus, type 2
22 results on '"Atkin S"'

Search Results

1. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes.

2. Platelet function following induced hypoglycaemia in type 2 diabetes.

3. Multinational Consensus: Insulin Initiation with Insulin Degludec/Aspart (IDegAsp).

4. Effect of soy on bone turn-over markers in men with type 2 diabetes and hypogonadism - a randomised controlled study.

5. LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimation.

6. Biological variation of cardiovascular risk factors in patients with diabetes.

7. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.

8. The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study.

10. High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: a pilot randomized controlled trial.

11. Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?

12. The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes.

13. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients.

14. For debate. Glucose variability and diabetes complication risk: we need to know the answer.

15. Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?

17. The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes.

18. Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target setting.

20. Improvement of glycaemic control with rebound following orlistat initiation and cessation associated with minimal weight change.

21. Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84.

22. Liraglutide and Renal Outcomes in Type 2 Diabetes

Catalog

Books, media, physical & digital resources